US Pharma MarketingBetting on biotech: Prediction markets set sights on clinical trials
One day in early May, web-based prediction market platform Kalshi listed two contracts tied to Compass Pathways’ psilocybin drug, COMP360. Several biotech contracts are rotating through Kalshi and Polymarket, while a recently launched clinical trial prediction market called Endpoint Arena is also on the rise. Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Trending Biologics Clinical Development Ophthalmology Cell & Gene Therapy Drug Development Small Molecule Research & Development Fierce 50 Special Report Awards Gala Awards Outsourcing Awards Innovation Awards Resources Fierce Events Industry Events Webinars…
Several biotech contracts are rotating through Kalshi and Polymarket, while a recently launched clinical trial prediction market called Endpoint Arena is also on the rise.
Source: FierceBiotech